The efficacy and safety of rifaximin-alpha: a 2-year observational study of overt hepatic encephalopathy

Research output: Contribution to journal › Article › Academic › peer-review

15 Citations (Scopus)

46 Downloads (Pure)

Original language	Undefined/Unknown
Article number	Unsp 175628481985825
Journal	Therapeutic Advances in Gastroenterology
Volume	12
DOIs	https://doi.org/10.1177/1756284819858256
Publication status	Published - 2019

Research programs

@article{01296e3f72a8473987de8fdab60b92bd,

title = "The efficacy and safety of rifaximin-alpha: a 2-year observational study of overt hepatic encephalopathy",

author = "Rosalie Oey and LEM Buck and Nicole Erler and \{van Buuren\}, Henk and \{de Man\}, Rob",

year = "2019",

doi = "10.1177/1756284819858256",

language = "Undefined/Unknown",

volume = "12",

journal = "Therapeutic Advances in Gastroenterology",

issn = "1756-283X",

publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - The efficacy and safety of rifaximin-alpha: a 2-year observational study of overt hepatic encephalopathy

AU - Oey, Rosalie

AU - Buck, LEM

AU - Erler, Nicole

AU - van Buuren, Henk

AU - de Man, Rob

PY - 2019

Y1 - 2019

U2 - 10.1177/1756284819858256

DO - 10.1177/1756284819858256

M3 - Article

C2 - 31258622

SN - 1756-283X

VL - 12

JO - Therapeutic Advances in Gastroenterology

JF - Therapeutic Advances in Gastroenterology

M1 - Unsp 175628481985825

ER -